# A Dose Escalation Study of Hydroxyurea in Combination With SCH900776 in Advanced Malignant Solid Tumors

> **NCT01521299** · PHASE1 · WITHDRAWN · sponsor: **Dartmouth-Hitchcock Medical Center**

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **DRUG:** Hydroxyurea

## Key facts

- **NCT ID:** NCT01521299
- **Lead sponsor:** Dartmouth-Hitchcock Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-03
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Insufficient population of eligible patients.
- **Last updated:** 2012-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01521299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01521299, "A Dose Escalation Study of Hydroxyurea in Combination With SCH900776 in Advanced Malignant Solid Tumors". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT01521299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*